Jul 13, 2026 Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
Jul 6, 2026 Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Jun 26, 2026 Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
Jun 10, 2026 Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Jun 2, 2026 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
May 21, 2026 Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
Mar 24, 2026 Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review